Kazia Therapeutics Limite... (KZIA)
NASDAQ: KZIA
· Real-Time Price · USD
6.77
0.21 (3.20%)
At close: Oct 06, 2025, 10:12 AM
Kazia Therapeutics Balance Sheet Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Cash & Equivalents | 3.06M | 1.66M | 3.56M | 5.24M | 4.39M | 7.36M | 15.19M | 27.59M | 19.37M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 40K | 40K | 40K | 42.92K | 3.72M | 7.3M | 6.93M | 6.69M | 7.17M |
Receivables | 88.44K | 133K | 65.39K | 610.00 | 700.97K | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | -105.03K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | 3.9M | n/a | 90.97K | n/a | 84.36K | n/a |
Total Current Assets | 3.41M | 6.14M | 8.01M | 10.77M | 5.92M | 9.45M | 16.71M | 29.39M | 20.58M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 14.47M | 15.4M | 16.33M | 17.27M | 18.2M | 19.14M | 21.03M | 22M | 11.87M |
Total Long-Term Assets | 14.51M | 15.44M | 16.37M | 17.31M | 21.92M | 26.44M | 27.96M | 28.7M | 19.04M |
Total Assets | 17.91M | 21.59M | 24.38M | 28.09M | 27.84M | 35.89M | 44.67M | 58.09M | 39.61M |
Account Payables | 6.33M | 4.55M | 1.04M | 857K | 2.31M | 1.52M | 2.35M | 1.89M | 2.52M |
Deferred Revenue | n/a | n/a | n/a | 4.16M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 140.74K | 634K | 359.3K | 1.8M | 552.32K | 1.84M | n/a | n/a | n/a |
Other Current Liabilities | 5.91M | 10.1M | 4.65M | 750K | 1.44M | 758.84K | 779.91K | 3.16M | n/a |
Total Current Liabilities | 16.51M | 25.8M | 11.34M | 7.57M | 5.58M | 6.73M | 7.59M | 8.33M | 2.72M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3.32M | 3.79M | 7.78M | 8.47M | 10.67M | 10.89M | 11.58M | 11.91M | 5.22M |
Total Long-Term Liabilities | 5.21M | 5.8M | 7.78M | 8.47M | 10.67M | -368 | 11.58M | -484 | 5.22M |
Total Liabilities | 21.72M | 31.6M | 19.12M | 16.03M | 16.25M | 6.73M | 19.18M | 8.33M | 7.94M |
Total Debt | 140.74K | 634K | 359.3K | 1.8M | 552.32K | 1.84M | n/a | n/a | n/a |
Book Value | -3.81M | -10.02M | 5.27M | 12.05M | 11.58M | 29.16M | 25.49M | 49.76M | 31.68M |
Book Value Per Share | -4.48 | -17.41 | 10.98 | 26.43 | 39.75 | 109.63 | 96.56 | 188.49 | 147.48 |
Common Stock | 117.46M | 101.64M | 98.78M | 97.45M | 90.34M | 84.48M | 80.31M | 80.29M | 72.39M |
Retained Earnings | -125.09M | -115.13M | -97.91M | -89.08M | -82.2M | -68.62M | -56.63M | -44.2M | -42.22M |
Comprehensive Income | 3.44M | 3.48M | 4.39M | -741.79K | 3.44M | 2.41M | 1.35M | 1.76M | 1.05M |
Shareholders Equity | -3.81M | -10.02M | 5.27M | 12.05M | 11.58M | 18.27M | 25.49M | 37.85M | 31.68M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |